91 related articles for article (PubMed ID: 9278273)
1. Introduction of spacer peptides N-terminal to a cleavage recognition motif in recombinant fusion proteins can improve site-specific cleavage.
Polyak SW; Forsberg G; Forbes BE; McNeil KA; Aplin SE; Wallace JC
Protein Eng; 1997 Jun; 10(6):615-9. PubMed ID: 9278273
[TBL] [Abstract][Full Text] [Related]
2. Linkers for improved cleavage of fusion proteins with an engineered alpha-lytic protease.
Lien S; Milner SJ; Graham LD; Wallace JC; Francis GL
Biotechnol Bioeng; 2001 Aug; 74(4):335-43. PubMed ID: 11410858
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of different enzymatic cleavage methods for recombinant fusion proteins, applied on des(1-3)insulin-like growth factor I.
Forsberg G; Baastrup B; Rondahl H; Holmgren E; Pohl G; Hartmanis M; Lake M
J Protein Chem; 1992 Apr; 11(2):201-11. PubMed ID: 1388667
[TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and in vitro characterization of recombinant salmon insulin-like growth factor-II.
Wilkinson RJ; Elliott P; Carragher JF; Francis G
Protein Expr Purif; 2004 Jun; 35(2):334-43. PubMed ID: 15135411
[TBL] [Abstract][Full Text] [Related]
5. Thrombin and H64A subtilisin cleavage of fusion proteins for preparation of human recombinant parathyroid hormone.
Forsberg G; Brobjer M; Holmgren E; Bergdahl K; Persson P; Gautvik KM; Hartmanis M
J Protein Chem; 1991 Oct; 10(5):517-26. PubMed ID: 1799410
[TBL] [Abstract][Full Text] [Related]
6. Production of biologically active recombinant tilapia insulin-like growth factor-II polypeptides in Escherichia coli cells and characterization of the genomic structure of the coding region.
Chen JY; Chang CY; Chen JC; Shen SC; Wu JL
DNA Cell Biol; 1997 Jul; 16(7):883-92. PubMed ID: 9260931
[TBL] [Abstract][Full Text] [Related]
7. Dual affinity fusion approach and its use to express recombinant human insulin-like growth factor II.
Hammarberg B; Nygren PA; Holmgren E; Elmblad A; Tally M; Hellman U; Moks T; Uhlén M
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4367-71. PubMed ID: 2543972
[TBL] [Abstract][Full Text] [Related]
8. Engineering subtilisin BPN' for site-specific proteolysis.
Carter P; Nilsson B; Burnier JP; Burdick D; Wells JA
Proteins; 1989; 6(3):240-8. PubMed ID: 2516317
[TBL] [Abstract][Full Text] [Related]
9. Hyperproduction of polyhedrin-IGF II fusion protein in silkworm larvae infected with recombinant Bombyx mori nuclear polyhedrosis virus.
Marumoto Y; Sato Y; Fujiwara H; Sakano K; Saeki Y; Agata M; Furusawa M; Maeda S
J Gen Virol; 1987 Oct; 68 ( Pt 10)():2599-606. PubMed ID: 3312489
[TBL] [Abstract][Full Text] [Related]
10. Production, in vitro characterisation, in vivo clearance, and tissue localisation of recombinant barramundi (Lates calcarifer) insulin-like growth factor II.
Degger B; Richardson N; Collet C; Upton Z
Gen Comp Endocrinol; 2001 Jul; 123(1):38-50. PubMed ID: 11551116
[TBL] [Abstract][Full Text] [Related]
11. A removable spacer peptide in an alpha-factor-leader/insulin precursor fusion protein improves processing and concomitant yield of the insulin precursor in Saccharomyces cerevisiae.
Kjeldsen T; Brandt J; Andersen AS; Egel-Mitani M; Hach M; Pettersson AF; Vad K
Gene; 1996 Apr; 170(1):107-12. PubMed ID: 8621069
[TBL] [Abstract][Full Text] [Related]
12. Active subtilisin-like protease from a hyperthermophilic archaeon in a form with a putative prosequence.
Kannan Y; Koga Y; Inoue Y; Haruki M; Takagi M; Imanaka T; Morikawa M; Kanaya S
Appl Environ Microbiol; 2001 Jun; 67(6):2445-52. PubMed ID: 11375149
[TBL] [Abstract][Full Text] [Related]
13. Purification and refolding of recombinant human IGF II from silkworms infected with recombinant Bombyx mori nuclear polyhedrosis virus.
Marumoto Y; Teruuchi T; Enjoh T; Numata F; Sakano K
Biosci Biotechnol Biochem; 1992 Jan; 56(1):13-6. PubMed ID: 1368125
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor (IGF)-II binding to IGF-binding proteins and IGF receptors is modified by deletion of the N-terminal hexapeptide or substitution of arginine for glutamate-6 in IGF-II.
Francis GL; Aplin SE; Milner SJ; McNeil KA; Ballard FJ; Wallace JC
Biochem J; 1993 Aug; 293 ( Pt 3)(Pt 3):713-9. PubMed ID: 7688957
[TBL] [Abstract][Full Text] [Related]
15. Substrate phage: selection of protease substrates by monovalent phage display.
Matthews DJ; Wells JA
Science; 1993 May; 260(5111):1113-7. PubMed ID: 8493554
[TBL] [Abstract][Full Text] [Related]
16. Chaperone-like effect during in vitro refolding of insulin-like growth factor I using a solubilizing fusion partner.
Samuelsson E; Uhlen M
Ann N Y Acad Sci; 1996 May; 782():486-94. PubMed ID: 8659919
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of recombinant human insulin-like growth factor II (IGF-II) expressed as a secreted fusion protein in Escherichia coli.
Wadensten H; Ekebacke A; Hammarberg B; Holmgren E; Kalderén C; Tally M; Moks T; Uhlén M; Josephson S; Hartmanis M
Biotechnol Appl Biochem; 1991 Jun; 13(3):412-21. PubMed ID: 1883532
[TBL] [Abstract][Full Text] [Related]
18. Influence of the four leader sequences of the human insulin-like-growth-factor-2 mRNAs on the expression of reporter genes.
De Moor CH; Jansen M; Bonte EJ; Thomas AA; Sussenbach JS; Van den Brande JL
Eur J Biochem; 1994 Dec; 226(3):1039-47. PubMed ID: 7813458
[TBL] [Abstract][Full Text] [Related]
19. Engineering subtilisin into a fluoride-triggered processing protease useful for one-step protein purification.
Ruan B; Fisher KE; Alexander PA; Doroshko V; Bryan PN
Biochemistry; 2004 Nov; 43(46):14539-46. PubMed ID: 15544324
[TBL] [Abstract][Full Text] [Related]
20. Accurate processing and secretion in the baculovirus expression system of an erythroid-cell-stimulating factor consisting of a chimaera of insulin-like growth factor II and an insect insulin-like peptide.
Congote LF; Li Q
Biochem J; 1994 Apr; 299 ( Pt 1)(Pt 1):101-7. PubMed ID: 8166627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
